Coalesce Capital and Freedom 3 Capital Recapitalize Examinetics
August 16, 2023
Coalesce Capital has completed a recapitalization of Examinetics alongside existing shareholder Freedom 3 Capital and company management. The investment will fund Examinetics' expansion into new markets and further development of its occupational health testing technologies (including its Salux auditory testing platform).
- Buyers
- Coalesce Capital, Freedom 3 Capital, Examinetics management
- Targets
- Examinetics
- Industry
- Healthcare Services
- Location
- Kansas, United States
- Transaction Type
- Recapitalization
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.